AI assistant
Sending…
CONMED Corp — Director's Dealing 2013
Jun 10, 2013
31971_dirs_2013-06-10_d79d49ad-7431-4fed-bfad-a468a6f17f44.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2013-06-07
Reporting Person: CORASANTI EUGENE R (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-06-07 | Common Stock | M | 500 | $26.69 | Acquired | 76759 | Direct |
| 2013-06-07 | Common Stock | F | 437 | $32.38 | Disposed | 76322 | Direct |
| 2013-06-07 | Common Stock | M | 500 | $16.46 | Acquired | 76822 | Direct |
| 2013-06-07 | Common Stock | F | 321 | $32.38 | Disposed | 76501 | Direct |
| 2013-06-07 | Common Stock | M | 500 | $19.26 | Acquired | 77001 | Direct |
| 2013-06-07 | Common Stock | F | 352 | $32.38 | Disposed | 76649 | Direct |
| 2013-06-07 | Common Stock | M | 500 | $27.63 | Acquired | 77149 | Direct |
| 2013-06-07 | Common Stock | F | 447 | $32.38 | Disposed | 76702 | Direct |
| 2013-06-07 | Common Stock | M | 2500 | $26.09 | Acquired | 79202 | Direct |
| 2013-06-07 | Common Stock | F | 2144 | $32.38 | Disposed | 77058 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-06-07 | Sars (Stock Appreciation Rights) | $26.69 | M | 500 | Disposed | 2018-06-01 | Common Stock (500) | Direct |
| 2013-06-07 | Sars (Stock Appreciation Rights) | $16.46 | M | 500 | Disposed | 2019-06-01 | Common Stock (500) | Direct |
| 2013-06-07 | Sars (Stock Appreciation Rights) | $19.26 | M | 500 | Disposed | 2020-06-01 | Common Stock (500) | Direct |
| 2013-06-07 | Sars (Stock Appreciation Rights) | $27.63 | M | 500 | Disposed | 2021-06-01 | Common Stock (500) | Direct |
| 2013-06-07 | Sars (Stock Appreciation Rights) | $26.09 | M | 2500 | Disposed | 2022-06-01 | Common Stock (2500) | Direct |
Footnotes
F1: The stock appreciation rights ("SARs") were granted under the Company's 2006 Stock Incentive Plan and generally vest in equal
amounts over a five year period.
F2: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.
F3: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan, with the SARs generally vesting 100% after a one year period.
More from CONMED Corp
Regulatory Filings
2026
Jun 1
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 20
Interim / Quarterly Report
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Regulatory Filings
2026
Apr 29
Major Shareholding Notification
2026
Apr 29
Annual Report
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7